Search results
Amgen 'encouraged' by weight-loss drug interim data, shares jump
AOL· 1 day agoShares of Amgen surged up 13% in after hours trading. Investors are highly focused on Amgen's pipeline of experimental weight-loss drugs, and the company said it expects to have data from the ...
Amgen shares jump after teasing ‘encouraging’ weight loss data
WHTC 1450 Holland· 9 hours ago(Reuters) - U.S. drugmaker Amgen's shares jumped 13% to $316.26 premarket on Friday as the company...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 2 days agoPrevnar sales inched 2% ahead to $6.44 billion. But other key products saw downfalls. Revenue from...
Pfizer (PFE) Q1 Earnings & Sales Top, EPS Guidance Raised
Zacks via Yahoo Finance· 2 days agoVyndaqel family sales beat the Zacks Consensus Estimate of $952.0 million as well as our model...
Here's What Key Metrics Tell Us About Amgen (AMGN) Q1 Earnings
Zacks· 2 days agoThe headline numbers for Amgen (AMGN) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Amgen first-quarter profit dips 1%, revenue rises 22%
Reuters via Yahoo Finance· 24 hours agoQuarterly product sales were led by an 8% jump for osteoporosis drug Prolia to $999 million, and a 33% increase to $517 million for cholesterol drug Repatha. Sales of rheumatoid arthritis drug ...
What's in the Cards for Amgen (AMGN) This Earnings Season?
Zacks via Yahoo Finance· 4 days agoVolume growth from Amgen's (AMGN) key drugs like Prolia, Repatha and Evenity, among others, is...
Insights Into Amgen (AMGN) Q1: Wall Street Projections for Key Metrics
Zacks via Yahoo Finance· 4 days agoGet a deeper insight into the potential performance of Amgen (AMGN) for the quarter ended March 2024...
UPDATE 1-Amgen first-quarter profit dips 1%, revenue rises 22%
Reuters via Yahoo Finance· 23 hours agoAmgen reported a slightly lower first-quarter profit on Thursday, citing higher operating and interest expense from its recent acquisition of rare disease drugmaker Horizon Therapeutics, partially ...
Amgen 'encouraged' by weight-loss drug interim data, shares jump
Reuters· 21 hours ago, opens new tab on Thursday said it was very encouraged after completing an interim analysis of its...
